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Abstract
Type 2 Myocardial Infarction (T2MI) is an increasingly recognized clinical entity due to the availability of
highly sensitive troponin assays for patients admitted due to common medical diagnoses. However, there
is little epidemiological data on the significance and long-term prognosis of T2MI, which occurs
secondary to an increase in myocardial oxygen demand and/or a decrease in myocardial blood flow.
Arrhythmia, hypoxia, and sepsis are the major etiologies for T2MI. Therefore, sepsis was the identified
area of interest for the study giving how common it is in a community hospital. We studied the cardiac
workup of patients with elevated troponin in the context of sepsis due to acute medical illness to find out
the prevalence of obstructive coronary artery disease (CAD) in this population. In this two-year
retrospective, descriptive study, electronic medical records (EMR) were reviewed for all patients aged 18
years and older admitted to a single community teaching hospital with a diagnosis of sepsis and elevated
troponin I (> 0.07 ug/L). The primary outcome was the presence of obstructive CAD. The secondary
outcome was time to peak serum troponin. Of 222 patients, 40 patients underwent invasive or/and
noninvasive cardiac testing for CAD. The study revealed 30% of patients admitted with T2MI due to sepsis
have underlying obstructive coronary artery lesions. Troponin rose slower in patients with T2MI with
underlying obstructive CAD. Pneumonia was the most common underlying cause of sepsis in both
groups. Given the considerable prevalence of underlying flow-limiting coronary artery lesions, it may be
advisable to evaluate for obstructive CAD sooner than later, during the index hospitalization, when
patients developed elevated troponin secondary to sepsis.
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Introduction
In 2007, the Task Force for the Universal Definition of Myocardial Infarction (MI) defined
five subtypes of MI. 1 Type 1 MI is the result of atherosclerotic coronary artery disease (CAD)
with coronary arterial obstruction secondary to plaque rupture, ulceration, fissuring, erosion, or
dissection. In contrast, Type 2 Myocardial Infarction (T2MI) does not have an atherosclerotic
plaque rupture as an underlying pathology, but, rather, myocardial ischemia and necrosis
secondary to a mismatch between myocardial oxygen supply and demand.2 Oxygen-carrying
capacity and coronary blood flow are the primary determinants of the myocardial oxygen supply,
while heart rate, systolic wall tension, and contractility define the myocardial demand. The most
common causes of T2MI are sepsis, arrhythmia, and anemia. 3 Septic patients with myocardial
dysfunction have a dramatic increase in mortality, as much as three-fold, compared to those with
normal cardiac function.4 The study aimed to explore the association between T2MI and
obstructive CAD among patients with T2MI secondary to sepsis, one of the most common
conditions admitted to the general medical floors at community hospitals.
Study Design and Population
The study was approved by the Rochester Regional Health Institutional Review Board. In
this two-year (October 2014 to October 2016) retrospective descriptive study, electronic charts
were reviewed for all patients aged 18 years and older, admitted to a single community teaching
hospital with elevated troponin and a diagnosis of sepsis.
The hospital used a sensitive cardiac troponin assay (Siemens Centaur TnI-Ultra, Siemens
Medical Solutions USA, Inc., Malvern, PA) with a positive value greater than 0.05 ug/L (above
the 99th percentile). In addition, a cut-off troponin level > 0.07 ug/L was selected to increase the
specificity of the selected sample. Diagnosis of sepsis was based on the International
Classification of Diseases (ICD) 9 code. Cases were verified against the 2001 Society of Critical
Care Medicine (SCCM) International Sepsis Definition 5.
T2MI was therefore defined as a significant rise of the troponin level > 0.07 ug/L in the
setting of sepsis without anginal symptoms or ischemic electrocardiogram (ECG) changes. The
diagnosis of T2MI was confirmed by the consulting cardiologists who were blinded to the study.
All selected patients underwent a cardiac evaluation for ischemia by either noninvasive cardiac
stress testing or coronary angiography. The choice of the test was clinician-dependent. The study
population was then divided into positive and negative cardiac testing. The positive cardiac testing
group is patients who ruled in for T2MI and were found to have either positive coronary
angiography or noninvasive cardiac stress testing. At the same time, the negative cardiac testing
group is those patients who ruled in for T2MI and were found to have negative coronary
angiography or noninvasive cardiac testing.
Exclusion criteria included: age less than 18 years, severe sepsis, septic shock, any history
of CAD prior to the index admission, ST-elevation myocardial infarction (STEMI), new left
bundle branch block on ECG, and/or resting wall motion abnormalities on transthoracic or
transesophageal echocardiogram suggestive of significant underlying CAD.
Data collection
Multiple variables were studied to examine their association with the primary outcome:
age, gender, body mass index (BMI), hypertension, hyperlipidemia, diabetes mellitus, current or
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prior tobacco use, previous cerebrovascular disease, peripheral vascular disease, chronic kidney
disease, chronic obstructive pulmonary disease, atrial fibrillation, medications, acute kidney
injury, underlying cause of sepsis, vital signs, ECG, echocardiogram, first troponin, peak troponin,
time to peak troponin, hemoglobin and white blood count.
Study objectives
The primary outcome of the study was the presence of obstructive CAD in patients with
sepsis and T2MI. The secondary outcome was time to peak serum troponin in T2MI. Subgroup
analyses of multiple clinical variables were performed to examine for prognostic value. An
obstructive coronary artery lesion was defined as any intraluminal coronary lesion requiring
medical intervention, percutaneous coronary intervention, or cardiac surgery. Multi-vessel
coronary artery disease is defined as more than one obstructive coronary lesion necessitating
percutaneous intervention or cardiac bypass surgery.
Statistical Analysis
Frequencies and percentages were calculated for the categorical and discrete variables,
respectively. A two-tailed P-value < 0.05 was considered statistically significant. Continuous
variables were summarized as means and standard deviations or median and interquartile range
(IQR) as appropriate. Means were compared with t-test and medians via Kruskal Wallis test.
Clinical significance for categorical variables was assessed using Pearson Chi-Square and Fisher's
exact test. All analyses were performed using Minitab 17 (Minitab, Inc., State College,
Pennsylvania, USA).
Results
There were 222 patients reviewed after being identified with a diagnosis of sepsis and elevated
troponin. Of those, 40 met the inclusion criteria (Figure 1). Reasons for exclusion were a known
history of CAD (72 patients), lack of cardiac workup (52 patients), comfort care (36 patients),
cardiac arrhythmia (7 patients), death (4 patients), refused cardiac evaluation (3 patients), STelevation MI (1 patient), and pericarditis (1 patient).

https://scholar.rochesterregional.org/advances/vol1/iss3/8
DOI: 10.53785/2769-2779.1039

2

Salama et al.: The role of coronary artery disease in demand mediated myocardial infarction

Of the 40 patients in the study population, 26 underwent a coronary angiogram, while 14
patients underwent non-invasive cardiac stress testing. Baseline characteristics of the study
population and comparison of clinical variables between the two groups are shown in Table 1 and
Figure 2. The clinical rationale behind selecting the ischemic evaluation test (coronary angiogram
vs. noninvasive stress test) was based on the assessment of the consulting cardiologist.
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Table 1: Demographic and Clinical Characteristics of the Patients in the two study
groups
Variables
Positive cardiac Negative cardiac
P value
workup (n=12)
workup (n=28)
Age, Median (IQR), Y
71 (64, 83)
73 (61, 82)
0.96
Female, n (%)
8 (67)
18 (64)
1
BMI, Median (IQR)
28 (23, 38)
32 (28,39)
0.16
Diabetes, n (%)
6 (50)
12 (43)
0.67
Hypertension, n (%)
11 (92)
24 (86)
1
Hyperlipidemia, n (%)
8 (67)
14 (50)
0.49
Current or ex-smoker,
8 (67)
16 (57)
0.73
n (%)
Prior CVA, n (%)
1 (8)
1 (4)
0.52
COPD, n (%)
3 (25)
7 (25)
1
CKD, n (%)
3 (25)
6 (21)
1
Atrial Fibrillation, n
3 (25)
5 (18)
0.68
(%)
Aspirin, n (%)
6 (50)
12 (43)
0.68
Beta-blocker, n (%)
7 (58)
10 (36)
0.19
Statin, n (%)
8 (67)
12 (43)
0.30
Nitrates, n (%)
1 (8)
1 (4)
0.52
Pneumonia, n (%)
7 (58)
16 (57)
0.94
Bacteremia, n (%)
2 (17)
6 (21)
1
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The study revealed 30% of patients admitted with T2MI due to sepsis have underlying
flow-limiting coronary artery lesions (10 patients with positive coronary angiogram and 2 patients
with positive cardiac stress testing, total 12 out of the 40 included patients). Of the 40 patients,
23% had underlying single-vessel coronary artery disease, while the multi-vessel disease was
diagnosed in 15% (Table 2). Three patients underwent PCI/PTCA, and two patients underwent
CABG.
Table 2. Summary of the coronary angiography results
Type of the coronary lesion
Number/Percent of patients
Single vessel disease, n (%)
6 (23)
Multi-vessel disease, n (%)
4 (15)
Non-obstructive coronary artery disease (CAD),
16 (62)
n (%)
Acute kidney injury was higher in T2MI with negative cardiac workup than those with
positive cardiac workup (50% vs. 8%, P= 0.015). Trends approaching significance were seen with
left ventricular hypertrophy (LVH) in T2MI with negative cardiac workup (26% vs. 17%, P=0.08).
Vital signs, median ejection fraction, first troponin level, and peak troponin level, among the rest,
were not statistically different between the positive and negative workup groups (Table 3). The
most common underlying cause for sepsis was pneumonia in both the positive and negative cardiac
workup groups (58% vs. 57%, p =0.94), followed by unknown source of bacteremia (17% vs. 21%,
p = 1.00).
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Table 3. Comparison between vital signs and the troponin measurements of the two
study groups
Variables
Positive
Negative cardiac
P value
cardiac
workup (n=28)
workup (n=12)
Febrile, n (%)
8 (67)
15 (54)
0.50
Maximum heart rate,
126.1 (18.5)
118 (23)
0.25
Mean (+/- SD)
Hemoglobin, Mean (+/12.28 (2.88)
11.84 (2.27)
0.64
SD), mg/dl
1st Trop, Median (IQR)
0.16 (0.03,
0.57 (0.50, 1.28)
0.81
1.95)
Peak Trop, Median
4.38 (3, 9.63)
3.40 (1.15, 5.38)
0.16
(IQR)
Time to peak Trop,
24 (16, 28)
9 (0, 26)
0.06
Median (IQR), hrs
Ejection Fraction,
50 (30, 59)
55 (38,60)
0.39
Median (IQR)
LVH, n(%)
17 (2)
26 (10)
0.08
AKI, n(%)
1 (8)
14 (50)
0.015
Noninvasive stress test, n 2 (17)
12 (43)
0.06
(%)
Coronary angiography, n 10 (83)
16 (57)
0.06
(%)

Discussion
The prevalence of underlying CAD in the T2MI population and the optimal means of
evaluation and treatment remain unclear. 6 The Centers for Medicare & Medicaid Services (CMS)
adopted a new MI classification schema with the release of ICD 10 codes in October 2017,
including code I21.A1 for Myocardial infarction type 2. 6,7 However, little epidemiological data is
available regarding T2MI. This is further compounded by the relatively recent introduction of the
term, suspected underreporting, and lack of established diagnostic criteria. 8 In our study, the
incidence of obstructive CAD in patients hospitalized for sepsis and T2MI was 30%, consistent
with other reports that showed an incidence between 15-40%. 9,10 However, most of these studies
did not focus solely on sepsis as the underlying etiology for T2MI. Myocardial dysfunction and
endothelial injury have been proposed as an underlying mechanism for transient biventricular
impairment of the left ventricle in septic patients, owing to the inflammatory cytokine release and
subsequent loss in membrane integrity with eventual troponin leakage. 11 However, the
inflammatory release with resultant myocardial dysfunction cannot account for the high prevalence
of obstructive CAD in T2MI.11 Other than the clinical context, the rise and/or fall pattern of cardiac
troponin values differentiates between acute myocardial injury and acute myocardial ischemia.
The latter could be type 1 or type 2, depending on the underlying etiology. 2
Our cohort had a preponderance of female and elderly patients. The population in the study
was generally healthy, with medical history mainly significant for hypertension and
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hyperlipidemia. Pre-existing CAD was excluded, as were other etiologies for T2MI, such as
arrhythmias and anemia, to empower the study results.
Troponin in the patients with T2MI and underlying obstructive CAD was detected as late
as 24 hours, compared to 9 hours in the group with negative testing for underlying CAD (Figure
3). This might suggest that following troponin for at least 24 hours would improve specificity for
diagnosing CAD among patients admitted with sepsis. However, larger prospective studies are
needed to confirm this hypothesis.

Pneumonia was the most common cause of sepsis in the study population; however, the
finding was not statistically significant (58% vs. 57%, p =0.94).
Acute kidney injury was higher in T2MI with negative cardiac workup, which can be
explained by the decreased renal clearance of cardiac troponin due to sepsis. LVH was more
common in T2MI patients with negative cardiac workup group, though not statistically significant,
likely explained by the higher oxygen requirement of the hypertrophied myocardium and therefore
is more likely to be stressed by any minor oxygen supply mismatch.
The observed mortality rate of 18% in our study is similar to previous studies, showing a
30-day mortality rate of 12.5% for patients with T2MI. 9,12 Overall, the mortality rates for the
patients with T2MI were generally higher than T1MI due to an increased prevalence of comorbid
medical conditions. 2 The observed mortality rate is all-cause mortality, so estimating diseasespecific mortality rate is difficult given the confounding factors, e.g., high incidence of sepsis and
comfort care measures in our population. Nearly half of the patients in the study were previously
prescribed beta-blockers and statins, which may have reduced their overall mortality; however,
there was no statistically significant difference in drug utilization rates among the groups.
The most recent guidelines do not address the acute or long-term management of T2MI
sufficiently. The question remains whether performing a cardiac evaluation, such as stress testing
or angiography, is necessary for T2MI. There is, however, a proposed algorithm to approach
patients with elevated cardiac troponin in the setting of acute illness, in which cardiac
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catheterization or C.T. coronary angiography were suggested in patients without a history of
CAD.13 Our findings support the validity of this approach giving the high proportion of the
underlying obstructive CAD in T2MI population. No firm evidence for medications such as
aspirin and beta-blockers in the T2MI population.9
Study Limitation
The retrospective nature limits our study. Also, the small number of patients, and singlecenter design, putting the generalizability of the results in need of validation by a larger sample.
Additionally, since some patients received interventional procedures and others underwent stress
tests, it is possible that the prevalence of CAD in those who underwent the stress test group was
underestimated. Also, we could not prove cause and effect due to the study's retrospective nature.
Conclusion
Almost one-third of patients admitted with T2MI due to sepsis may have underlying flowlimiting coronary artery lesions. It may, therefore, be reasonable to evaluate for obstructive disease
when patients present with sepsis and T2MI. There is an urgent need for evidence-based diagnostic
and therapeutic strategies, primarily randomized, controlled clinical trials to guide the management
of T2MI.
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